Compare SMHI & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMHI | AMRN |
|---|---|---|
| Founded | 1989 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.7M | 304.3M |
| IPO Year | 2016 | 1998 |
| Metric | SMHI | AMRN |
|---|---|---|
| Price | $6.89 | $14.40 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 74.9K | 41.8K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.41 | 55.00 |
| EPS | N/A | ★ N/A |
| Revenue | $173,783,000.00 | ★ $181,104,000.00 |
| Revenue This Year | $1.21 | N/A |
| Revenue Next Year | $9.31 | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $4.32 | $9.44 |
| 52 Week High | $8.17 | $20.90 |
| Indicator | SMHI | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 35.07 | 43.76 |
| Support Level | $6.71 | $13.69 |
| Resistance Level | $6.92 | $14.49 |
| Average True Range (ATR) | 0.27 | 0.60 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 1.72 | 25.62 |
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that (i) deliver cargo and personnel to offshore installations, including offshore wind farms, (ii) assist offshore operations for production and storage facilities, (iii) provide construction, well work-over, offshore wind farm installation and decommissioning support and (iv) carry and launch equipment used underwater in drilling and well installation, maintenance, inspection and repair. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America, with the majority of revenue deriving from the Africa and Europe segment.
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.